Europe Drug Modelling Software Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 – COVID-19 Impact and Analysis – by Product Type (Database, Software, and Others); and Application (Drug Discovery and Development, Computational Physiological Medicine, Disease Modelling, Medical Imaging, Predictive Analysis of Drug Targets, Simulation Software, Cellular Simulation, and Others)

No. of Pages: 108    |    Report Code: TIPRE00013989    |    Category: Technology, Media and Telecommunications

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Drug Modelling Software Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Drug Modelling Software Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Drug Modelling Software Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Adoption of Modelling Tools in Drug Discovery
  • 5.1.2 Increasing Economic Burden of Drug Discovery
5.2 Market Opportunities
  • 5.2.1 Strategic Activities by Market Players
5.3 Future Trends
  • 5.3.1 Growing Adoption of Artificial Intelligence in Drug Discovery
5.4 Impact of Drivers and Restraints

6. Europe Drug Modelling Software Market Regional Analysis

6.1 Europe Drug Modelling Software Market Overview
6.2 Europe Drug Modelling Software Market Revenue 2017-2027 (US$ Million)
6.3 Europe Drug Modelling Software Market Forecast Analysis

7. Europe Drug Modelling Software Market Analysis – by Product Type

7.1 Database
  • 7.1.1 Overview
  • 7.1.2 Database: Europe Drug Modelling Software Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Software
  • 7.2.1 Overview
  • 7.2.2 Software: Europe Drug Modelling Software Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Drug Modelling Software Market Analysis – by Application

8.1 Drug Discovery and Development
  • 8.1.1 Overview
  • 8.1.2 Drug Discovery and Development: Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Computational Physiological Medicine
  • 8.2.1 Overview
  • 8.2.2 Computational Physiological Medicine: Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Disease Modelling
  • 8.3.1 Overview
  • 8.3.2 Disease Modelling: Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Medical Imaging
  • 8.4.1 Overview
  • 8.4.2 Medical Imaging: Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Predictive Analysis of Drug Targets
  • 8.5.1 Overview
  • 8.5.2 Predictive Analysis of Drug Targets: Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Simulation Software
  • 8.6.1 Overview
  • 8.6.2 Simulation Software: Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Cellular Simulation
  • 8.7.1 Overview
  • 8.7.2 Cellular Simulation: Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Drug Modelling Software Market – Europe Analysis

9.1 Europe
  • 9.1.1 Europe Drug Modelling Software Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 9.1.1.1 Europe Drug Modelling Software Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 UK: Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.1.1.1.1 UK: Europe Drug Modelling Software Market Breakdown, by Product Type
    • 9.1.1.1.2 UK: Europe Drug Modelling Software Market Breakdown, by Application
  • 9.1.1.2 Germany: Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.1.1.2.1 Germany: Europe Drug Modelling Software Market Breakdown, by Product Type
    • 9.1.1.2.2 Germany: Europe Drug Modelling Software Market Breakdown, by Application
  • 9.1.1.3 France: Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.1.1.3.1 France: Europe Drug Modelling Software Market Breakdown, by Product Type
    • 9.1.1.3.2 France: Europe Drug Modelling Software Market Breakdown, by Application
  • 9.1.1.4 Russia: Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.1.1.4.1 Russia: Europe Drug Modelling Software Market Breakdown, by Product Type
    • 9.1.1.4.2 Russia: Europe Drug Modelling Software Market Breakdown, by Application
  • 9.1.1.5 Italy: Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.1.1.5.1 Italy: Europe Drug Modelling Software Market Breakdown, by Product Type
    • 9.1.1.5.2 Italy: Europe Drug Modelling Software Market Breakdown, by Application
  • 9.1.1.6 Rest of Europe: Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.1.1.6.1 Rest of Europe: Europe Drug Modelling Software Market Breakdown, by Product Type
    • 9.1.1.6.2 Rest of Europe: Europe Drug Modelling Software Market Breakdown, by Application

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Europe Drug Modelling Software Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Crown Bioscience Inc (JSR life science)
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Genedata AG
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Biognos AB
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Dassault Systèmes
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Acellera
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - Europe Drug Modelling Software Market

The List of Companies - Europe Drug Modelling Software Market

  1. Crown Bioscience Inc (JSR life science)
  2. Genedata AG
  3. Biognos AB
  4. Dassault Systèmes
  5. Acellera
europe-drug-modelling-software-market